CVS Health’s new subsidiary Cordavis will help manufacturers produce and/or commercialize biosimilars with the aim of reducing overall drug costs while improving access to and affordability of medicines.

Most of the other leaders in the new organization within the Centers for Medicare and Medicaid Services tasked with implementing the price negotiation and inflation rebate programs previously worked in other parts of the agency, including the Center for Medicare and Medicaid Innovation.

Congressional scrutiny aside, ‘the rebate model remains alive and well’ as the big three pharmacy benefit managers exclude around 600 drugs each from their formularies.

As health insurance lobby launches advertising campaign to defend ‘evidence-based, market-driven tools,’ drug firms point out the connection between insurers and pharmacy benefit managers.